Vertex has established itself as a frontrunner in the indirect tax automation space, serving over 4,800 customers, including more than 60% of the Fortune 500. The company’s solutions are ...

Average 5-Year Revenue Growth: 25.83% Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a biotech company dedicated to ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biopharmaceutical company with a market capitalization of $131.2 billion, has been making significant strides in the treatment of cystic fibrosis (CF) ...